Pharma Stock Surging on Upbeat Covid-19 Treatment Data

The stock is getting ready to topple several layers of resistance

Digital Content Manager
Apr 11, 2022 at 9:27 AM
facebook twitter linkedin


Another company could be joining the ranks of Covid-19 treatment producers: Veru Inc (NASDAQ:VERU). The biopharmaceutical firm this morning released upbeat results for its Phase 3 Covid-19 oral treatment, showing that the oral sabizabulin treatment led to a "clinically and statistically meaningful" 55% reduction in deaths in hospitalized adults. The shares of Veru are soaring in response, last seen up 29.9% at $5.65. 

VERU is set to open at its highest level since early March this morning. Should these gains hold, it could also topple dual resistance at its $5.50 level and its 30-day moving average, which rejected a rally attempt late last month. VERU came into today sporting a 58% year-over-year deficit, and on Friday's session, the stock touched an annual low of $4.34. 

Despite this recent rout, analysts remain optimistic. All five in coverage call it a "strong buy." What's more, the 12-month consensus price target of $24.20 is an eyebrow-raising 320.1% premium to last night's close. 

Short sellers are hitting the exits, with short interest falling 11.7% in the last reporting period, but there's still room for a short squeeze to push the stock higher. The 3.25 million shares sold short make up 5.4% of the stock's available float, and would take nearly three days to cover, at VERU's average daily pace of trading. 

 

Stop leaving money on the table with the same old broken options trading approach...

There is no options strategy that more perfectly capitalizes during earnings season better than this simple call and put buying strategy. Perfect for aggressive traders looking to recover their suffering portfolios so far in 2022. With the simplest possible options strategy, Schaeffer's team with 100+ years of options trading excellence, target 200% gains on every single trade. So many trades are being beaten down by the market, but don't be one of them! Don't waste another second... join us right now before the next trade is released! 

 
Schaeffer's Daily Bulletin Offer
 


 


 
Special Offers from Schaeffer's Trading Partners